Sustacal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sustacal

Property Description
Active Ingredient Comprehensive mix of Macronutrients (Protein, Carbohydrate, Fat) and Micronutrients (Vitamins A, D, E, K, B12, C, Iron, Calcium, Zinc, etc.)
Form Liquid Preparation (Ready-to-use)
Pharmacological Class Complete Nutritional Supplement / Enteral Nutrition Preparation
Common Use Nutritional Management of dietary deficits
Origin Commercial Formula

What is Sustacal and Its Classification?

Sustacal is defined as a commercially formulated, multi-nutrient liquid product belonging to the Complete Nutritional Supplement class, which is widely recognized as an Enteral Nutrition Preparation. This combination product is standardized to deliver comprehensive caloric and nutrient intake when a regular diet is insufficient or compromised. The preparation is designed for flexible delivery, allowing for either Oral consumption or Enteral administration via a feeding tube, distinguishing its application in clinical dietary management.

Unlike many generic supplements, Sustacal is often known for its high-protein concentration, making it a recognized choice for nutritional scenarios requiring significant tissue repair and muscle maintenance. The product is utilized for nutritional management as a dietary product, not a prescription drug.


Comprehensive Composition: Macronutrients and Micronutrients

The identity of Sustacal is rooted in its extensive list of active ingredients, encompassing all essential nutritional components. This formula includes high-quality Protein sources, complex Carbohydrates, and essential Fat components, alongside a complete array of Vitamins (A, B12, C, D, E, K, etc.) and key Minerals (Calcium, Iron, Zinc, Potassium, etc.).

This composition ensures reliable caloric delivery and supports the body's structural and metabolic needs. Furthermore, many commercial formulations are readily available as a gluten-free preparation, accommodating specific clinical dietary requirements. This formula provides essential macronutrients and micronutrients for medical dietary support.


General Purpose of Sustacal as Nutritional Support

The overarching purpose of Sustacal is to provide direct, reliable nutritional support to manage or prevent dietary deficits stemming from insufficient oral intake or heightened metabolic demands. By guaranteeing a dependable baseline of macronutrients and micronutrients, the product is clinically recognized for supporting fundamental physiological needs and facilitating protein synthesis and the preservation of lean body mass.

What side effects are possible with Sustacal?

Possible Side Effects and Safety Information

The safety profile for this complete nutritional supplement is primarily defined by the body's tolerance to the volume and composition of enteral nutrition, aligning with official regulatory guidance on nutritional support preparations.

System-Organ Classes and Common Adverse Effects

The most frequently reported effects are classified as Gastrointestinal Disorders. These reactions are generally considered Common and are often linked to the formula's volume or osmotic concentration. Patients may experience symptoms such as nausea, diarrhea, abdominal distension, vomiting, flatulence, or constipation. These gastrointestinal effects are noted as being more common upon initiation of administration as the digestive system adjusts to the new nutritional intake.

Serious Adverse Reactions

Certain significant safety concerns associated with the practice of nutritional support are documented in official sources:

  • Refeeding Syndrome: A potentially serious metabolic complication involving rapid shifts in fluid and electrolytes (e.g., severe hypophosphatemia) that can occur when nutritional support is initiated in individuals who are severely malnourished.
  • Aspiration: A serious safety concern, particularly when administered via tube feeding, where the liquid formula enters the respiratory system.
  • Fluid Overload: A risk classified under Metabolism and Nutrition Disorders that may affect patients with pre-existing, severe fluid restrictions or cardiac impairment.

Safety-Related Restrictions

Official safety documentation includes high-level constraints based on the formula’s ingredients and the patient's underlying condition. The formula is generally contraindicated for individuals with specific, rare metabolic disorders such as galactosemia, due to the composition of its carbohydrate components. Furthermore, official safety guidance requires attention to potential food allergies (e.g., to milk or soy proteins) that may be present in the formula.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for overdose of Sustacal, a Complete Nutritional Supplement, centers on the acute toxicity of its micronutrient components and the physiological stress of excessive nutritional volume. This information is derived strictly from government regulatory documentation.


Documented Overdose Manifestations and Actions

Classification Official Regulatory Statement
Documented Manifestations Acute component toxicity, specifically from the Iron content, may present as severe gastrointestinal distress, including nausea, vomiting, and diarrhea. This can progress to systemic deterioration, including lethargy and features of hypovolemic shock if left untreated.
Severe Outcomes Accidental overdose of iron-containing products is officially documented as a risk for fatal poisoning in vulnerable populations.
When to Seek Immediate Help Regulators mandate that immediate medical attention must be sought for any known or suspected accidental overdose. Consumers are instructed to call a doctor or poison control center immediately due to the life-threatening risk associated with acute toxicity.
Supportive Management Management of the multi-nutrient formula is described as symptomatic and supportive treatment, as no single pharmacological antidote is documented for the complete composition. Hospital monitoring is often required.

Population-Specific Overdose Risk

Regulatory agencies explicitly identify children less than 6 years of age as a high-risk population. Accidental overdose of iron-containing products is officially recognized as a leading cause of fatal poisoning in this age group, underscoring the necessity for urgent care.

Therapeutic Uses of Sustacal

The core therapeutic function of Sustacal, as a complete nutritional supplement, is used to provide comprehensive macro- and micronutrient support when the standard diet is insufficient or compromised due to illness. The use of this type of nutritional support is aligned with established practices in enteral nutrition, making it relevant for patients who cannot maintain adequate oral intake to meet their metabolic demands. Its use aligns with established guidance on nutritional support.

Uses and Therapeutic Benefit

Sustacal is primarily applied in the management of protein-calorie malnutrition and significant nutritional deficits, supporting individuals in convalescence and those facing hypercatabolic states following surgery or acute illness. It is commonly used to help with symptom patterns associated with sarcopenia and frailty and is relevant for managing cases of poor appetite (anorexia) or difficulty eating/swallowing (dysphagia). This supportive nutrition contributes to supporting the overall recovery process and functional return, and provides supportive assistance for energy when eating is a challenge. This nutritional support is applicable across conditions where symptoms create noticeable physiological strain or functional stability becomes affected.

Quick Fact: Relief for Fatigue and Weakness Sustacal is generally used to provide supportive relief for symptoms related to energy and protein deficit, which contributes to easing the overall symptom load of fatigue and weakness during recovery phases.

Regulatory References

  1. National Library of Medicine on Enteral Nutrition

Eligibility and Restrictions for Use

Who Can and Cannot Use Sustacal?

Sustacal is classified by regulatory authorities as a Complete Nutritional Supplement (enteral preparation), and its eligibility rules are based on its composition and designated administration route, rather than on pharmacological restrictions typically associated with prescription medicines.


Eligibility and Restrictions

Category Regulatory Status
Absolute Contraindication Individuals with Galactosemia must not use this product, as its nutritional components cannot be metabolized due to this specific metabolic disorder.
Prohibited Administration Route Use is strictly limited to the oral or enteral (tube) route; intravenous (IV) administration is explicitly prohibited for this product class.
Targeted Age Group The product is specifically designed to meet the nutritional needs of older adults (geriatric population). Use in children and adolescents is permissible but requires specific medical determination.
Conditional Eligibility Eligibility for government-funded access may be conditioned on a documented medical necessity, such as a diagnosis of malnutrition or significant involuntary weight loss, as defined by coverage programs.

Summary of Eligibility Profile

Official documents define who can and cannot use Sustacal primarily through two lenses: composition suitability and route of administration. The absolute exclusion of those with Galactosemia is a mandatory restriction based on the formula’s components. All other constraints, such as the prohibition of intravenous use and the need for a documented nutritional deficit to qualify for public coverage, serve to define the product’s intended and conditional user populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sustacal, a complete nutritional supplement, is not associated with enzyme-mediated drug metabolism but has officially documented interactions stemming from its composition of minerals and vitamins.

Exposure-Modifying and Efficacy Interactions

Interacting Substance/Class Official Interaction Pattern Contextual Constraint
Warfarin (Anticoagulant) The formula’s Vitamin K content is documented to reduce the anticoagulant effect, potentially leading to therapeutic failure. Efficacy is reduced.
Phenytoin (Anti-seizure) Reduced plasma concentration (exposure) due to binding to the formula components or the feeding tube. Risk is heightened with continuous enteral feeding.
Fluoroquinolones & Tetracyclines (Antibiotics) Reduced oral absorption due to chelation by the high content of divalent cations like Iron and Calcium. Reduced drug exposure.

Timing-Based Administration Rules

To mitigate the risk of reduced drug exposure, mandatory administration rules are defined in official guidelines. For medications susceptible to chelation, such as fluoroquinolones and tetracyclines, administration must be separated from the nutritional formula by a minimum of two hours. Similarly, when administering phenytoin to patients on continuous enteral tube feeding, the feed must be temporarily interrupted (e.g., one to two hours before and after the dose) to ensure adequate drug absorption. No contraindicated combinations are officially documented.

Mechanism of Action

Sustacal facilitates cellular energy production through the direct delivery of macronutrients as substrates. The protein component is hydrolyzed in the gastrointestinal tract into constituent amino acids, which enter the circulation for use in protein synthesis pathways and as precursors in various metabolic cascades, including gluconeogenesis. The carbohydrate content, primarily complex and simple sugars, undergoes digestion to glucose. Circulating glucose is transported into cells via GLUT receptors to be metabolized through glycolysis, initiating the tricarboxylic acid (TCA) cycle and subsequent oxidative phosphorylation for ATP generation. The lipid fraction provides fatty acids and glycerol, which are catabolized via beta-oxidation to acetyl-CoA, feeding into the TCA cycle. Vitamins and minerals serve as enzyme cofactors and electron carriers necessary to maintain the activity of specific metabolic pathways, such as the synthesis of nucleic acids and the maintenance of membrane potential. Collectively, these inputs modulate the systemic availability of substrates for anabolic and catabolic cellular processes.

Dosage and Administration Information

How to Use Sustacal — Official Administration Guidelines

The usage of Sustacal is governed by guidelines for enteral nutrition preparations, defining administration by serving size and delivery method under clinical oversight.

Administration Scope

Instruction Detail
Official Routes Oral consumption or Enteral administration via a feeding tube, providing flexible dietary management.
Dosing Schedule Use is defined by standardized serving sizes; for supplementation, this typically involves two servings daily, delivered in a volume of approximately 230 mL per serving.
Preparation Powdered forms require reconstitution with liquid before use. The liquid formula is administered ready-to-use but may be poured and served with meals.
Age-Group Rules Primarily intended for adults and older adults. Use in pediatric cases is typically limited to specific, strictly authorized medical conditions.

Procedural Structure and Use Constraints

Administration must proceed under medical supervision for the dietary management of a specific condition. A key procedural constraint involves the handling of the liquid preparation: any product poured from the container must be consumed or discarded within a 6-hour window if left at room temperature to maintain product integrity. This preparation and handling protocol defines the procedural steps for its proper administration.

The official instructions establish a standardized protocol for providing complete nutritional support, focusing on flexible delivery methods and precise serving guidelines to achieve daily caloric goals.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sustacal

Evidence for Use in Managing Malnutrition and Nutritional Risk

Research involving complete nutritional supplements, such as Sustacal, has been conducted in Randomized Controlled Trials (RCTs) and Systematic Reviews that combine the results of many studies. This nutritional preparation was evaluated in research involving populations at risk of or experiencing protein-calorie malnutrition, particularly during periods of convalescence. Studies examined measurements of nutritional status by monitoring metrics like body weight, BMI, and nutritional screening scores.

Research explored outcomes related to physical function, which were measured using scales for factors like grip strength and walking ability. Studies also monitored clinical outcomes related to systemic or functional imbalance, such as the incidence of Complications and patterns of Healthcare Utilization, including hospital re-admissions. What remains uncertain are the long-term outcomes beyond the initial measured changes, as follow-up durations were often limited to about six months.


Evidence for Support in Acute and Critical Care Settings

The research base for these nutritional preparations in acute environments is structured around short-term Randomized Controlled Trials. These nutritional preparations were evaluated in research conducted during periods of increased symptom activity where patients were often unable to take food orally. The research examined severe clinical outcomes, including Clinical Mortality (such as 28-day and ICU death rates) and metrics of Healthcare Utilization.

Data show patterns related to caloric intake and subsequent monitoring of clinical outcomes. However, the evidence is limited, and certainty remains low for reducing overall mortality or length of stay when comparing different caloric regimens. Subgroup findings are uncertain because the evidence is derived from settings with varying symptom burdens and a high degree of patient complexity.


What is Still Uncertain About the Research

Evidence highlights what is known—and what is still uncertain—about this class of nutritional product. Evidence quality varies across studies, and findings were mixed concerning measurements of specific functional or muscle mass metrics. Follow-up durations were limited in many studies, meaning long-term effects are not fully established. Research provides context but does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Sustacal (FAQ)


Q: Is Sustacal appropriate for long-term daily consumption?

Official evidence indicates that research follow-up durations for this type of nutritional product are often limited. Studies examined outcomes for periods of up to about six months. Therefore, the available evidence base suggests that long-term effects beyond the six-month period are not fully established.


Q: Is Sustacal a lactose-free or gluten-free nutritional product?

Official product information confirms that many commercial versions of Sustacal are readily available as a gluten-free preparation. However, the ingredient list explicitly specifies the inclusion of Milk Protein derived from cow's milk. The presence of milk components is a factor to consider based on individual dietary needs.


Q: Does the product contain a high amount of sugar or artificial ingredients?

According to the official nutritional panel, the powder is primarily composed of carbohydrates. Per 100 g of powder, 60.0 g is carbohydrate, of which 55.0 g are Total Sugars. The ingredients also include Sucrose (sugar).


Q: Does Sustacal help with weight maintenance or is it only intended for weight gain?

The official purpose is to provide nutritional support to manage or prevent dietary deficits and support overall nutritional status. Research studies examine the product's effect on metrics like body weight and BMI. Its role in managing overall nutritional status supports its use for both weight maintenance and addressing dietary deficits.


Q: What makes Sustacal particularly recommended for older adults?

Official product information indicates Sustacal is designed to meet the nutritional needs of older adults. The formulation provides comprehensive support, including a high-energy content and components included to support strength and active lifestyle.


Q: Can individuals with a dairy protein sensitivity still use Sustacal?

The product's ingredient list specifies the use of Milk Protein from cow's milk. Official safety information notes the importance of checking for potential food allergies, such as to milk or soy proteins, due to the formula’s composition.


Q: Is Sustacal meant to replace a full meal or is it strictly a supplement?

Sustacal is officially classified as a Complete Nutritional Supplement and an Enteral Nutrition Preparation. It is administered via the oral or enteral route to provide complete nutritional support. The formula is designed to provide comprehensive nutritional support, aligning with its classification as a complete source of nutrition.


Q: Does Sustacal contain probiotics or prebiotics, and how do they function?

Official product information confirms that the formula contains both Probiotics and a Prebiotic blend. These are generally associated with supporting a healthy microbial gut environment.


Q: Is Sustacal suitable for individuals who are managing their blood sugar levels?

The official nutritional panel lists a low Glycemic Index (GI) for the powder formulation, ranging from 36 to 37. This factual information is provided on the label for reference.


Q: How can I find official information about research evidence for Sustacal?

Information summarizing the research base, which includes Randomized Controlled Trials and Systematic Reviews related to nutritional support, is often available in public databases. These sources include the National Library of Medicine (NIH) or the official regulatory documents of government health bodies.


Q: Can Sustacal be consumed by individuals following a vegetarian diet?

Official product information states that the formula's primary protein source is Milk Protein derived from cow's milk. The formula contains ingredients that align with its classification as a cow's milk-derived product.


Q: What is the energy content in Sustacal derived mainly from fat or carbohydrates?

The nutritional panel shows that the largest component of the formula by weight is Carbohydrate, which is 60.0 g per 100 g of powder. The large percentage of carbohydrate suggests this component is the primary source of caloric delivery.


Q: Do different flavors of Sustacal have the same core nutritional breakdown?

The nutritional panel reveals that different flavors of the product may have slight variations in their core nutritional breakdown. For instance, there are minor differences in total energy and fat content between the Chocolate and Vanilla flavors.


Q: What is the protein source used in the Sustacal formulation?

Official product information confirms that the formula's protein is sourced from Milk Protein (from cow’s milk), which includes Whey protein.


Q: How does the immune-boosting claim relate to the ingredients in Sustacal?

The formula contains specific ingredients such as Probiotics and Prebiotics. These components are described in official product materials as helping to support a healthy microbial gut environment, which is generally associated with supporting immune function.

How should Sustacal be stored and disposed of?

How to Store and Dispose of Sustacal?

The storage and disposal instructions for Sustacal, a liquid nutritional supplement, are defined by regulatory standards to maintain product quality and safety.


Storage Conditions

Unopened Product: Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from freezing, excessive heat, and direct sunlight. Store in its original container and keep it out of the sight and reach of children.

Opened Product: Once opened, any unused portion must be covered, sealed, and immediately refrigerated. The official instruction is to discard any unused liquid after 24 hours, even if continuously refrigerated, to prevent spoilage.


Disposal

Disposal of expired or unused Sustacal product must be carried out according to local regulations for liquid nutritional waste. The product is not classified as hazardous medicinal waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sustacal found in:

A-Z Index: